Guardant Health Inc. Common Stock vs Sun Life Financial Inc. Common Stock — how do they compare? Guardant Health Inc. Common Stock trades at $161.95 (market cap $21.74B), while Sun Life Financial Inc. Common Stock trades at $77.62 (market cap $43.44B). The key difference: Sun Life Financial Inc. Common Stock is the larger of the two by market cap, and Sun Life Financial Inc. Common Stock pays a 3.47% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 3 Days and Sun Life Financial Inc. Common Stock for 0 Days on average.
| GH | SLF | |
|---|---|---|
Market Cap | $21.74B | $43.44B |
Volume | 1,297,295 | 333,821 |
Sector | Health | Financials |
52-Week High | $187.22 | $84.07 |
52-Week Low | $64.19 | $57.60 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $22.38B | $45.17B |
Dividend Yield | — | 3.47% |
Signals from Pluang's Aura AI — not financial advice
Guardant Health (GH) trades at $162.09, down 0.43% today, with a bearish technical signal despite strong analyst support. The company shows robust revenue growth to $982M in 2025 but remains unprofitable with a -38.33% net margin. Recent FDA and European approvals for cancer diagnostics and expanded insurance coverage provide significant growth catalysts.
Investment outlook balances high growth potential against persistent losses. Analyst consensus is strongly bullish with a $202.40 price target (25% upside), but investors face execution risk as the company burns cash and misses earnings estimates. The stock offers substantial upside if Guardant can achieve profitability through its expanding product portfolio.
Sun Life Financial (SLF) trades at $77.87, up 0.69% on the day, reflecting steady momentum. The stock shows consistent earnings beats in recent quarters, with Q3 2026 results pending. Financial health is solid, with a P/E of 18.82 and robust cash flow projections for 2026. Recent strategic moves include expanding disability benefits and forming a reinsurance partnership, signaling growth initiatives.
The outlook for SLF is cautiously optimistic, supported by earnings strength and strategic expansions. Key risks include competitive pressures and macroeconomic volatility. Analyst sentiment is mixed, with a majority hold rating, suggesting potential stability but limited near-term upside. Investors should weigh solid fundamentals against sector headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →Sun Life Financial Inc. is a Canada-based financial services company providing insurance, wealth and asset management, and health solutions for individuals and institutions. Its products span life, health, and disability insurance along with mutual funds and pension asset management, through operations in Canada, US, the United Kingdom, Ireland, and across Asia.
Read more on SLF →